Patents by Inventor Sandra Sofia Pereira Rodrigues

Sandra Sofia Pereira Rodrigues has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170157168
    Abstract: The invention relates to the use of carbon monoxide (CO) to inhibit the gastrointestinal side effects caused by non-steroidal anti-inflammatory drugs (NSAIDs) and/or alcohol.
    Type: Application
    Filed: July 25, 2016
    Publication date: June 8, 2017
    Inventors: Sandra Sofia Pereira Rodrigues, Joaõ D. Seixas, Bruno Guerreiro, Nuno Miguel Penacho Pereira, Carlos C. Romão, Werner E. Haas, Isabel Goncalves
  • Publication number: 20160137679
    Abstract: Provided herein are novel carbon-monoxide releasing molecules (CO-RMs) of the Formula (I): and esters, amides, salts, solvates and hydrates thereof; wherein R1 and R2 are as described herein. Also provided are pharmaceutical compositions comprising these compounds, methods of their preparation, and their use in the treatment of liver disease and inflammation.
    Type: Application
    Filed: September 8, 2015
    Publication date: May 19, 2016
    Applicant: Alfama, Inc.
    Inventors: Walter Anton Blättler, Carlos J.R.C. Romão, Sandra Sofia Pereira Rodrigues, Lukas Adrian Kromer, Leo Edmond Otterbein, David John Gallo
  • Patent number: 9163044
    Abstract: Provided herein are novel carbon-monoxide releasing molecules (CO-RMs) of the Formula (I): and esters, amides, salts, solvates and hydrates thereof; wherein R1 and R2 are as described herein. Also provided are pharmaceutical compositions comprising these compounds, methods of their preparation, and their use in the treatment of liver disease and inflammation.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: October 20, 2015
    Assignee: Alfama, Inc.
    Inventors: Walter Anton Blättler, Carlos J. R. C. Romão, Sandra Sofia Pereira Rodrigues, Lukas Adrian Kromer, Leo Edmond Otterbein, David John Gallo
  • Publication number: 20140212514
    Abstract: The invention relates to the use of carbon monoxide (CO) to inhibit the gastrointestinal side effects caused by non-steroidal anti-inflammatory drugs (NSAIDs) and/or alcohol.
    Type: Application
    Filed: October 11, 2013
    Publication date: July 31, 2014
    Applicant: ALFAMA - Investigacao e Desenvolvimento de Produtos Farmaceuticos, Lda.
    Inventors: Sandra Sofia Pereira Rodrigues, Joaõ D. Seixas, Bruno Guerreiro, Nuno Miguel Penacho Pereira, Carlos C. Romão, Werner E. Haas, Isabel Goncalves